Wu Qing, the chairman of China Securities Regulatory Commission (CSRC), has sought approval to step down from his role, sources familiar with the matter told Reuters, in an abrupt move that could create uncertainty for the country’s stock markets. Wu, appointed in February 2024 to stabilize China’s markets, reportedly cited health reasons for his intended departure. It remains unclear whether his resignation has been accepted or when he would officially leave the office, one of the most influential regulatory positions in the world’s second-largest economy.
Wu’s potential exit comes at a sensitive time for Chinese markets, which have rebounded strongly under his leadership. The Shanghai Composite Index has risen roughly 45% since his appointment, outperforming the 35% gain of the MSCI world index. Investors have credited Wu’s reform-minded approach and decisive interventions for restoring confidence, but analysts warn that his departure could unsettle markets. Zhang Jianan, a Shanghai-based fund manager at Wen Ding Capital, told Reuters that Wu’s resignation would likely hurt investor expectations given his reputation as the architect of recent capital market reforms.
Known for his previous regulatory stints, Wu earned the nickname “broker butcher” after cracking down on securities firms. Before assuming the CSRC chairmanship, he held senior roles including deputy party chief of Shanghai and head of the Shanghai Stock Exchange, and had spent years tackling insider trading and market risks. Wu’s elevation to the CSRC came after the sudden removal of his predecessor Yi Huiman amid market turmoil in early 2024, with Yi now under investigation for serious disciplinary violations.
Wu’s tenure saw a series of market interventions, liquidity measures, and governance reforms that bolstered both domestic and international investor sentiment. Eugene Hsiao, head of China equity strategy at Macquarie Capital, told Reuters that the market will closely watch whether a dovish or reform-minded successor is appointed, as the future of China’s “slow bull” market hinges on the new leadership at CSRC. While Wu’s health reasons are cited for his exit, the implications for market stability and ongoing reforms are expected to be closely scrutinized in the coming weeks.
